The embryonic stem cell cycle (ESCC) and let-7 families of miRNAs function antagonistically in the switch between mouse embryonic stem cell self-renewal and somatic differentiation. Here, we report that the human ESCC miRNA miR-372 and let-7 act antagonistically in germline differentiation from human embryonic stem cells (hESCs) and human induced pluripotent stem cells (iPSCs). hESC and iPSC-derived primordial germ cell-like cells (PGCLCs) expressed high levels of miR-372 and conversely, somatic cells expressed high levels of let-7. Manipulation of miRNA levels by introduction of miRNA mimics or knockdown with miRNA sponges demonstrated that miR-372 promotes whereas let-7 antagonizes PGCLC differentiation. Knockdown of the individual miR-372 targets SMARCC1, MECP2, CDKN1, RBL2, RHOC, and TGFBR2 increased PGCLC production, whereas knockdown of the let-7 targets CMYC and NMYC suppressed PGCLC differentiation. These findings uncover a miR-372/let-7 axis regulating human primordial germ cell (PGC) specification. STEM CELLS 2016;34:1985-1991 
INTRODUCTION
The generation of human germ cells in vitro provides a promising avenue to study the molecular basis of their development as functional studies are not feasible. Successful differentiation of primordial germ cell-like cells (PGCLCs) from ESCs has been reported in mouse [1] and human [2] [3] [4] . Importantly, in vitro differentiation recapitulates many major events observed in vivo [3] [4] [5] [6] , and mouse PGCLC function has been demonstrated with successful spermatogenesis and oogenesis resulting in live births [7, 8] .miRNAs are short single-stranded RNAs that destabilize transcripts and repress translation primarily through partial complementation with the 3 0 UTRs of target mRNAs [9] . Several miRNAs have been implicated in primordial germ cell (PGC) development [5, 10] . In particular, let-7 blocks the production of mouse PGCs both in vitro and in vivo, at least in part through the key PGC specification transcription factor, Prdm1 (Blimp1) [5] . The knockout of the miR-290 cluster in mice results in a subfertile phenotype with a reduction in PGCs, but the specific targets remained to be investigated [11] . The miR-290 cluster (or miR-372 cluster in humans) consists of a combination of miRNAs, including members of the embryonic stem cell cycle (ESCC) family, which have been shown to antagonize the let-7 family in the differentiation of embryonic stem cells [12] . Here, we aimed to dissect the roles of the let-7 and ESCC miRNAs and their targets in the production of human PGCs using an in vitro model of human PGCLC differentiation.
MATERIALS AND METHODS
Human embryonic stem cell (hESC) lines (H1, H9), and induced pluripotent stem cell (iPSC) lines (BJ3, BJ4) were differentiated as previously described [2] with slight modifications. See supplementary materials for all methods including: cell culture; flow cytometry; RT-qPCR; western blot analysis; bisulfite sequencing; design and introduction of siRNAs, miRNA mimics, Lin28, Prdm1 shRNA, and miRNA sponges; luciferase reporter assays; and statistical methods.
RESULTS AND DISCUSSION
To evaluate the roles of miRNAs in PGC development, we differentiated human ESCs and iPSCs in medium containing retinoic acid and then enriched for PGCLCs by fluorescencebased sorting using SSEA-1 and C-Kit [1, 2] . Differentiation of hESCs and iPSCs resulted in 2.5-3.2% cells co-expressing both PGCLC markers, referred to as double-positive (DP) (Fig. 1A-1C ). Somatic cells lacking these markers are referred to as double-negative (DN). DP cells expressed high levels of VASA and DAZL with concomitant up regulation of PRDM1, DAZL, SYCP3, NANOG, POU5F1, and SOX17 ( Fig. 2A-2E ), similar to previous studies [3, [13] [14] [15] [16] . However, SYCP3 immunolocalized to nuclear puncta without synaptonemal complex formation in 29% of PGCLCs, suggesting they have not entered meiosis (Fig. 2F ). High levels of H3K27me3 and H3K9me2 were observed in H9 derived DP and DN cells, respectively (Supporting Information Fig. S1A ), consistent with epigenetic reprogramming of in vivo PGCs and somatic cells during development [17] [18] [19] [20] . Partial demethylation of the imprinted H19, PEG1, and SNRPN loci was also observed in the PGCLCs (Supporting Information Fig. S1B ), as found in mouse and human PGCs at late-migratory, pre-meiotic stages [2-4, 14, 21] .
Since the ESCC and let-7 families of miRNAs function antagonistically in the switch between mESC self-renewal and differentiation [12] , we asked whether they function similarly in the reactivation of pluripotency during PGC specification. The ESCC miRNA miR-372 was highly expressed in H9 derived DP cells whereas let-7 was undetectable (Fig. 3A) ; the converse was found in DN cells. Introduction of miR-372 mimics into H9 and H1 hESCs prior to differentiation increased the frequency of DP cells from 2.8 to 4.7% (1.7-fold) whereas let-7 mimics had the opposite effect (2.8-0.7%, 0.25-fold) (Fig.  3B ), suggesting antagonizing roles of these miRNAs in PGCLC derivation. miRNA sponges [22] were used to knockdown endogenous miR372 and let-7 function in hESCs and the specificity of the sponges was confirmed with target derepression as shown in Supporting Information Fig. S2A-S2D . Sponge introduction did not alter the pluripotency of hESCs as they fully retained the capacity for multilineage differentiation as assessed by embryoid body formation (Supporting Information Fig. S2E ). Subsequently, H9 hESCs expressing these sponges were differentiated as described above. Although the let-7 sponge significantly promoted PGCLC formation (1.7-fold), the miR-372 sponge abolished it (Fig. 3C) . The positive effect of the let-7 sponge on DP cell yield was recapitulated by the overexpression of LIN28, an inhibitor of let-7 biogenesis ( Fig.  S3A-S3C ). Combined knockdown of let-7 with miR-372 mimic addition further augmented the yield of DP cells (2.7-fold) (Fig. 3C) , supporting antagonistic roles of miR-372 and let-7 in PGCLC production.
In addition to modulating the frequencies of DP cells, miR-372 and let-7 also altered expression of germ cell genes. We found that miR-372 mimic increased, whereas let-7 decreased the levels of PRDM1, VASA, DAZL, and SYCP3 in H9 derived DP cells (Fig. 3D) . In contrast, these mimics had the opposite effect on somatic markers HOXA1 and HOXB1 in the H9 derived DP cells (Fig. 3E) . The frequency of SYCP3-expressing PGCLCs increased from 29% in the control group to 51% in the miR-372 treated group (Fig. 3F) . miR-372 mimic also enhanced epigenetic reprogramming, as demethylation of the H19, PEG1, and SNRPN loci was more complete (Fig. 3G , Supporting Information S1B). Thus, in addition to the overall frequency and efficiency of PGCLC differentiation, miR-372 and let-7 also impacted the quality of PGCLC development.
To distinguish between the possible function for miR-372 and let-7 in either specification or maintenance of PGCLCs, we introduced mimics at either day 0 or day 3 during differentiation of H9 hESCs. miR-372 enhanced germ cell marker expression within the DP cell population exclusively when introduced at day 0, but not day 3. In contrast, let-7 significantly suppressed PRDM1, VASA, SYCP3, and POU5F1 expression even when introduced 3 days after differentiation (Fig. 4A) . Furthermore, miR-372 led to a small, but significant increase in phosphorylated histone H3 (PHH3) positive DP cells relative to control and let-7 mimic when transfected at day 0, suggesting a positive effect of miR-372 on PGCLC proliferation (Fig. 4B) . Together, these data implicate miR-372 in production and early expansion of PGCLCs, and let-7 as a suppressor of their specification and maintenance. The ESCC miRNAs promote dedifferentiation of somatic cells back to induced pluripotent stem cells (iPSCs) through repression of multiple targets including cell cycle regulators (CDKN1A, RBL2, CDC2L6), epithelial-mesenchymal transition regulators (RHOC, TGFBR2), and epigenetic regulators (MECP2, SMARCC2) [23] . To test a potentially parallel role of miR-372 in the specification of PGCLCs, which involves reactivation of the pluripotency program in mice [18] , we evaluated 11 targets of the ESCC miRNAs previously tested in human iPSC production. [23] . Knockdown of six of the eleven targets increased the fraction of PGCLCs to from the baseline of 1% to the range of 1.97-2.8%, representing an increase of 1.8-2.5-fold (Fig. 4C) . These findings suggest that ESCC miRNAs function through similar pathways to promote PGCLC production during hESC differentiation and iPSC production during human somatic cell dedifferentiation. Previous studies demonstrated that the let-7 target Prdm1 inhibits the mouse ESC to PGC transition [4, 5] . Introduction of let-7 similarly suppressed PRDM1 in human cells (Fig. 3D) . Knockdown of PRDM1 led to near abolishment of DP cells (Supporting Information Fig. S3D-S3E ). Since let-7 has been shown to target MYC genes in ESCs promoting ESC differentiation [12] , we asked whether MYC ablation similarly affects PGCLC production. Individual knockdown of CMYC and NMYC significantly decreased DP cell frequency suggesting that MYC activity enhances hPGCLC specification (Fig. 4D) . Therefore, like the ESCC miRNAs, the let-7 miRNAs share common targets in the regulation in PGCLC production and ESC selfrenewal.
CONCLUSION
These results support a model by which the ESCC and let-7 miRNAs have opposing effects on the production of hPGCLCs from pluripotent cells (Fig. 4E) . Knockout of the miR-290 cluster in mouse, which contains both ESCC miRNAs orthologous to human miR-372 and non-ESCC miRNAs, results in a depletion of PGCs, although the specific miRNAs targets and mechanisms involved remaine unclear [11] . As shown here, miR-372 augments PGC numbers through the suppression of multiple pathways including cell cycle (CDKN1A, RBL2, CDC2L6), EMT (RHOC, TGFBR2), and epigenetic regulators (MECP2, SMARCC2). Suppression of these targets can also enhance human iPSC formation [23] . In contrast, let-7 inhibits PGCLC formation in part through the suppression of MYC, a target which also promotes ESC differentiation [12, 24] . Thus, these miRNA-regulated networks are common to the production of iPSCs and PGCs, both of which involve a reactivation of pluripotency. Given the success of miRNA manipulation in improving the efficiency of iPSC production, our studies suggest that similar strategies will be successful in rapidly evolving protocols for in vitro PGC derivation [3, 4] . The expression of miRNAs in such new protocols and potential synergy with miR-372/let7 is an important area of future experimentation.
